Accendra Health Statistics
Want to see ACH full AI Analyst Report?
Accendra Health (ACH) Stock Statistics & Valuation Metrics
Total Valuation
Accendra Health has a market cap or net worth of $10.16M. The enterprise value is $1.87B.
- Market Cap
- $10.16M
- Enterprise Value
- $1.87B
Share Statistics
Accendra Health has 76,965,324 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 76,965,324
- Owned by Insiders
- 3.80%
- Owned by Institutions
- 47.31%
Financial Efficiency
Accendra Health’s return on equity (ROE) is 2.39 and return on invested capital (ROIC) is 12.33%.
- Return on Equity (ROE)
- 2.39
- Return on Assets (ROA)
- -0.45
- Return on Invested Capital (ROIC)
- 12.33%
- Return on Capital Employed (ROCE)
- 0.15
- Revenue Per Employee
- 424.93K
- Profits Per Employee
- -169.33K
- Employee Count
- 6,500
- Asset Turnover
- 1.13
- Inventory Turnover
- 19.79
Valuation Ratios
The current PE Ratio of Accendra Health is -0.06. Accendra Health’s PEG ratio is -0.00.
- PE Ratio
- -0.06
- PS Ratio
- 0.00
- PB Ratio
- -0.02
- Price to FCF
- -0.06
- Price to Operating Cash Flow
- -0.40
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Accendra Health had revenue of 2.76B and earned -1.10B in profits. Earnings per share was -14.31.
- Revenue
- 2.76B
- Gross Profit
- 1.29B
- Operating Income
- 221.74M
- Pretax Income
- -101.95M
- Net Income
- -1.10B
- EBITDA
- 219.75M
- Earnings Per Share (EPS)
- -14.31
Cash Flow
In the last 12 months, operating cash flow was -25.31M and capital expenditures -138.52M, giving a free cash flow of -163.83M billion.
- Operating Cash Flow
- -25.31M
- Free Cash Flow
- -163.83M
- Free Cash Flow per Share
- -2.13
Dividends & Yields
Accendra Health pays an annual dividend of $0.00, resulting in a dividend yield of ―
- Dividend Per Share
- $0.00
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1613.89%
- Earnings Yield
- -1689.94%
Stock Price Statistics
- Beta
- 1.35
- 52-Week Price Change
- -95.49%
- 50-Day Moving Average
- 0.53
- 200-Day Moving Average
- 2.15
- Relative Strength Index (RSI)
- 24.10
- Average Volume (3m)
- 2.46M
Important Dates
Accendra Health upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Feb 24, 2027
- Ex-Dividend Date
- Dec 14, 2021
Financial Position
Accendra Health as a current ratio of 0.58, with Debt / Equity ratio of -484.57%
- Current Ratio
- 0.58
- Quick Ratio
- 0.50
- Debt to Market Cap
- 10.05
- Net Debt to EBITDA
- 8.88
- Interest Coverage Ratio
- 2.07
Taxes
In the past 12 months, Accendra Health has paid 729.00K in taxes.
- Income Tax
- 729.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
Accendra Health EV to EBITDA ratio is 13.01, with an EV/FCF ratio of -11.20.
- EV to Sales
- 0.72
- EV to EBITDA
- 13.01
- EV to Free Cash Flow
- -11.20
- EV to Operating Cash Flow
- -72.51
Balance Sheet
Accendra Health has $26.61M in cash and marketable securities with $1.85B in debt, giving a net cash position of -$1.82B billion.
- Cash & Marketable Securities
- $26.61M
- Total Debt
- $1.85B
- Net Cash
- -$1.82B
- Net Cash Per Share
- -$23.71
- Tangible Book Value Per Share
- -$24.31
Margins
Gross margin is 44.13%, with operating margin of 1.60%, and net profit margin of -6.72%.
- Gross Margin
- 44.13%
- Operating Margin
- 1.60%
- Pretax Margin
- -5.83%
- Net Profit Margin
- -6.72%
- EBITDA Margin
- 5.53%
- EBIT Margin
- -0.64%
Analyst Forecast
The average price target for Accendra Health is $0.25, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- $0.25
- Price Target Upside
- 89.39% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 2
- Revenue Growth Forecast
- -61.96%
- EPS Growth Forecast
- 87.15%
Scores
- Smart Score
- ―
- AI Score
- 40

